Latest Breaking News On - Kwon young jin - Page 4 : comparemela.com

Healthcare & PharmaceuticalsSamsung BioLogics shares ease after jumping on vaccine deal Joyce LeeSangmi Cha 4 minute read A vial containing the Moderna COVID-19 vaccine is seen at a temporary vaccination center of Swiss Medix health center as the spread of the coronavirus disease continues, in the Offene St. Jakob Kirche Reformed church in Zurich, Switzerland May 12, 2021. REUTERS/Arnd Wiegmann Samsung BioLogics (207940.KS) shares ended lower on Monday, after rising as much as 5.2% on the South Korean contract drug maker s deal to make Moderna s (MRNA.O) COVID-19 vaccine, one of four such contracts announced in the country. The companies gave no details on how many vaccines will be made as part of the fill and finish deal that will run through 2022. This type of a contract involves putting vaccines into vials or syringes, sealing them and packaging them up for shipping, but not making the vaccine itself. read more

United statesSouth koreaSouth koreanKwon young jinSamsung biologicsJoe bidenCo ltdThomson reuters trust principlesVaccine partnershipPrevention agencySamsung biologicSouth korean president moon jae inKorea disease controlMayor kwon young jinThomson reuters trustஒன்றுபட்டது மாநிலங்களில்